Piper Sandler Downgrades Cerevel Therapeutics (CERE) to Neutral
Tweet Send to a Friend
(Updated - December 7, 2023 4:34 AM EST)
Piper Sandler analyst David Amsellem downgraded Cerevel Therapeutics (NASDAQ: CERE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst David Amsellem downgraded Cerevel Therapeutics (NASDAQ: CERE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
